Immunogenicity of Pfizer-BioNTech COVID-19 mRNA Primary Vaccination Series in Recovered Individuals Depends on Symptoms at Initial Infection

Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, Julie Carbonneau, Henintsoa Rabezanahary, Marie-Ève Hamelin, Deirdre McCormack, Patrice Savard, Yves Longtin, Matthew P. Cheng, Gaston De Serres, Jacques Corbeil, Vladimir Gilca, Mariana Baz, Guy Boivin, Caroline Quach, Hélène Decaluwe
doi: https://doi.org/10.1101/2022.03.29.22272714

Article Information

doi 
https://doi.org/10.1101/2022.03.29.22272714
History 
  • April 2, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Sabryna Nantel, Ph.D. candidate1,2,
  2. Benoîte Bourdin, (Ph.D.)1,
  3. Kelsey Adams, (M.Sc.)3,
  4. Julie Carbonneau, (M.Sc.)4,5,
  5. Henintsoa Rabezanahary, (Ph.D.)4,5,12,
  6. Marie-Ève Hamelin, (Ph.D.)4,5,
  7. Deirdre McCormack, (B.Sc.(N))3,
  8. Patrice Savard, (M.D.)2,6,
  9. Yves Longtin, (M.D.)7,
  10. Matthew P. Cheng, (M.D.)8,
  11. Gaston De Serres, (M.D.)5,9,10,
  12. Jacques Corbeil, (Ph.D.)5,11,
  13. Vladimir Gilca, (M.D.)5,9,10,
  14. Mariana Baz, (Ph.D.)4,5,12,
  15. Guy Boivin, (M.D.)4,5,
  16. Caroline Quach, (M.D.)2,3,* and
  17. Hélène Decaluwe, (M.D.)1,2,13,*,†
  1. 1Cytokines and Adaptive Immunity Lab, Sainte-Justine University Hospital and Research Center, Montréal, QC, Canada
  2. 2Microbiology, Infectiology and Immunology Department, Faculty of Medicine, University of Montréal, QC, Canada
  3. 3Sainte-Justine University Hospital and Research Center, Montréal, QC, Canada
  4. 4Infectious Disease Research Center, Université Laval, Québec City, QC, Canada
  5. 5CHU de Québec - Université Laval Research Center, Québec City, QC, Canada
  6. 6Montreal University Hospital and Research Center, Montréal, QC, Canada
  7. 7Jewish General Hospital, Montréal, QC, Canada
  8. 8Divisions of Infectious Diseases and Medical Microbiology, Departments of Medicine and Laboratory Medicine, McGill University Health Center, Montréal, QC, Canada
  9. 9Institut National de Santé Publique du Québec, Québec City, QC, Canada
  10. 10Preventive and Social Medicine Department, Université Laval, Québec City, QC, Canada
  11. 11Molecular Medicine Department, Université Laval, Québec City, QC, Canada
  12. 12Microbiology, Infectiology and Immunology Department, Université Laval, Québec City, QC, Canada
  13. 13Pediatric Immunology and Rheumatology Division, Department of Pediatrics, University of Montréal, QC, Canada
  1. ↵†CORRESPONDING AUTHOR
    Hélène Decaluwe, CHU Sainte-Justine Research Center, 3175, Chemin de la Côte-Sainte-Catherine, Montréal, QC, Canada (H3T 1C5), 1-514-345-4931 (EXT. 5075), helene.decaluwe{at}umontreal.ca
Back to top
Posted April 02, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Immunogenicity of Pfizer-BioNTech COVID-19 mRNA Primary Vaccination Series in Recovered Individuals Depends on Symptoms at Initial Infection
Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, Julie Carbonneau, Henintsoa Rabezanahary, Marie-Ève Hamelin, Deirdre McCormack, Patrice Savard, Yves Longtin, Matthew P. Cheng, Gaston De Serres, Jacques Corbeil, Vladimir Gilca, Mariana Baz, Guy Boivin, Caroline Quach, Hélène Decaluwe
medRxiv 2022.03.29.22272714; doi: https://doi.org/10.1101/2022.03.29.22272714
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area